IP Library Granted Patent US 9,938,549
Granted Patent B2
US 9,938,549 · App. 14/700,038 · Granted Apr 10, 2018

Process for producing monosaccharides

Inventors: Stefan Jennewein (Bad Honnef, DE); Katja Parschat (Rheinbreitbach, DE)
Assignee: Jennewein Biotechnologie GmbH
C12P19/02C12N9/1051C12N9/2402C12P19/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,938,549
App. No.
14/700,038
Granted
Apr 10, 2018
Kind
B2
Abstract

The present invention relates to a process for producing a monosaccharide using a microorganism. The microorganism possesses a glycosyltransferase and a glycosidase which work together to synthesize a desired monosaccharide in free form by using an endogenous provided nucleotide activated monosaccharide, glycosylate a suitable acceptor substrate and release the desired monosaccharide by a hydrolysis reaction. The required acceptor substrate for the reaction is recycled and only needed in catalytic amounts. The monosaccharide is produced in free from and is retrieved from the supernatant of the cultivated microorganism.

Claims (18)

1. A process for producing L-fucose in free form using a bacterial microorganism, the process comprising the steps of:

a) providing a recombinant bacterial microorganism that has been transformed to contain a nucleic acid sequence encoding a bacterial alpha-1,2-fucosyltransferase specifically able to transfer fucose from an activated nucleotide fucose to lactose to form a lactose-fucose substrate, or to lactulose to form a lactulose-fuscose substrate, and a nucleic acid sequence encoding a bacterial 1,2-alpha-fucosidase not naturally occurring in the recombinant bacterial microorganism, the bacterial 1,2-alpha-fucosidase able to release the L-fucose from the lactose-fucose substrate or from the lactulose-fucose substrate, wherein the recombinant bacterial microorganism lacks a beta-galactosidase gene or comprises a deregulated beta-galactosidase-encoding gene, and wherein the recombinant bacterial microorganism is unable to metabolize L-fucose;

b) cultivating the recombinant bacterial microorganism in a medium suitable for growing the recombinant bacterial microorganism, whereby L-fucose is produced in a free form; and

c) recovering the L-fucose from the medium.

2. The process of claim 1 , wherein the medium comprises a carbon source, and wherein the carbon source is glycerol, sucrose, molasses, xylose, cellulose, or syngas.

3. The process of claim 1 , wherein cultivating the recombinant bacterial microorganism is a batch or a continuous process.

4. The process of claim 1 , wherein recovering free L-fucose from the medium comprises centrifuging the cultivated recombinant bacterial microorganism to obtain a supernatant and a recombinant bacterial microorganism pellet, and recovering the free L-fucose from the supernatant.

5. A process for producing L-fucose in free form using a bacterial microorganism, the process comprising the steps of:

a) providing a recombinant E. coli host cell that has been transformed to contain i) a wbgL gene encoding a bacterial alpha 1,2-fucosyltransferase, wherein the alpha 1,2-fucosyltransferase can transfer the fucose from an activated nucleotide fucose to lactose or lactulose to form a lactose-fucose-substrate or a lactulose-fucose-substrate, and ii) an afcA gene encoding a 1,2-alpha-fucosidase not naturally occurring in the recombinant E. coli host cell, wherein the 1,2-alpha-fucosidase can release L-fucose from the lactose-fucose-substrate or the lactulose-fucose-substrate; wherein the recombinant E. coli host cell is unable to metabolize the L-fucose;

b) cultivating the recombinant E. coli host cell in a medium suitable for growing the recombinant E. coli host cell, whereby L-fucose is produced in a free form; and

c) recovering the L-fucose from the medium.

6. The process of claim 5 , wherein the recombinant E. coli host cell is further transformed to contain the gal-operon (galETKM) genes and the lactose transporter gene lacY.

7. The process of claim 6 , wherein the medium comprises a carbon source, and wherein the carbon source is glycerol, sucrose, molasses, xylose, cellulose, or syngas.

8. The process of claim 6 , wherein cultivating the recombinant E. coli is a batch or a continuous process.

9. The process of claim 6 , wherein recovering free L-fucose from the medium comprises centrifuging the cultivated E. coli host cell to obtain a supernatant and a E. coli host cell pellet, and recovering the free L-fucose from the supernatant.

10. The process of claim 1 , wherein the recombinant bacterial microorganism is a recombinant Escherichia coli.

11. The process of claim 1 , wherein the alpha-1,2-fucosyltransferase is encoded by a wbgL gene of E. coli.

12. The process of claim 1 , wherein the 1,2-alpha-glycosidase is encoded by an afcA gene of Bifidobacterium bifidum.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2025
From: CHR. HANSEN HMO GMBH
To: CHR. HANSEN A/S
Reel/Frame 070396/0299 →
CHANGE OF NAME Recorded Jun 22, 2021
From: JENNEWEIN BIOTECHNOLOGIE GMBH
To: CHR. HANSEN HMO GMBH
Reel/Frame 057701/0507 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 20, 2015
From: JENNEWEIN, STEFAN; PARSCHAT, KATJA
To: JENNEWEIN BIOTECHNOLOGIE GMBH
Reel/Frame 036139/0454 →
Priority Claims (1)
EP 12190801 · Oct 31, 2012 · regional
Continuity (2)
Continuation PCTEP2013068579 · Sep 9, 2013
Related Publication 20150240277A1 · Aug 27, 2015